KLF4-dependent modulation of phenotype switching in VSMCs was shown to be pathogenic, and deletion of this gene in a murine model of atherosclerosis reduced lesion size73, suggesting that targeting modulators of CTD in atherosclerosis may be an effective treatment strategy. The gene discussed is KLF4; the disease is atherosclerosis.